Multiple types of Hepatic Lesions ( Masses) in the same patient.

Показать описание

This video shows Multiple types of Hepatic Lesions ( Masses) in the same patient.
A liver Hemangioma, also known as a hepatic hemangioma, is a benign (non-cancerous) tumor in the liver that is made up of clusters of blood-filled cavities fed by the hepatic (liver) artery. Usually, a patient has only one hemangioma, but in some cases, there may be more than one.
Hemangioma is the most common benign tumor in the liver, with the prevalence varying from 1–2% to 20%. In greyscale ultrasound, hemangiomas typically appear as hyperechoic, well-defined lesions, or hypoechoic masses with a hyperechoic periphery
Hepatic hemangioma. Hepatic hemangiomas are benign vascular liver lesions. They are frequently diagnosed as an incidental finding on imaging, and most patients are asymptomatic. From a radiologic perspective, it is important to differentiate hemangiomas from hepatic malignancy.
Hepatic hemangiomas are much more common in females, with an F: M of up to 5:1
Ultrasound
Hepatic hemangiomas are the most common benign liver tumors which can be often diagnosed radiologically. However, despite their typical radiologic findings, giant pedunculated hemangiomas are rare and often misdiagnosed as a supra-renal, retroperitoneal, gastric, or mesenteric mass.
Hepatic tumors are a diverse group of masses that include malignant and benign subtypes. Their presentation may vary from localizing signs/symptoms, such as jaundice and right upper quadrant pain, to vague signs/symptoms, such as fatigue, weight loss, and anorexia. Many hepatic tumors are discovered incidentally on medical imaging studies. Moreover, the liver is a common site for metastasis, and metastases to the liver are significantly more common than primary liver tumors.
The incidence of primary liver cancer is steadily increasing worldwide.
Unlike most other causes of liver disease, it is treatable and the prognosis is excellent provided that it is diagnosed before irreversible damage has occurred.
The most common causes of cirrhosis are hepatitis and other viruses. Alcohol abuse. Nonalcoholic fatty liver disease (this happens from metabolic syndrome and is caused by conditions such as obesity, high cholesterol and triglycerides, and high blood pressure),
Most benign liver tumors do not cause symptoms and are found incidentally on abdominal imaging studies such as an ultrasound, CT scan, or MRI. It is important that benign tumors are not misdiagnosed. Your doctor may choose to follow the tumor with imaging studies to ensure that they have been diagnosed correctly.
Globally, liver cancer is the third leading cause of cancer death after cancers of the lung and the stomach. The highest incidence of hepatocellular carcinoma (HCC) is in China, representing about 50% of HCC cases worldwide, with most of the cases associated with hepatitis B virus (HBV) infection. Cholangiocarcinoma also has a disproportionate geographical distribution, with Thailand having the highest global rates due to the presence of liver flukes.
Accurate characterization of liver masses by cross-sectional imaging is liver disease with cirrhosis, portal hypertension, and hypersplenism. Focal fat is also hyperechoic to the normal liver parenchyma on ultrasound.
Liver metastases mean that cancer in one part of the body has spread to a person's liver. In these cases, the person has advanced, or stage 4, cancer. The prognosis for liver metastases tends to be poor, with a roughly 11% survival rate for 5 years.
Liver metastases are cancerous tumors that have spread (metastasized) to the liver from another part of the body. These tumors can appear shortly after the original tumor develops, or even months or years later. This information is about cancer that has spread to the liver.